CAD 17.9
(0.11%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 10.41 Million | 15.23 Million | 16.22 Million | 20.61 Million | -4.14 Million | 16.2 Million |
Net Income | 29.43 Million | 35.5 Million | 18.68 Million | 22.08 Million | 17.32 Million | 26.26 Million |
Depreciation & Amortization | 363 Thousand | 273 Thousand | 261 Thousand | 280 Thousand | 286 Thousand | 303 Thousand |
Deferred income taxes | 10.61 Million | 13.62 Million | 7.76 Million | 6.46 Million | 4.38 Million | 10.14 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -2.68 Million | 2.69 Million | -694 Thousand | 5.5 Million | -5.55 Million | 44 Thousand |
Other non-cash items | -22.97 Million | -36.86 Million | -6.77 Million | -10.96 Million | -14.76 Million | -27.24 Million |
Investing Cash Flow | 56 Thousand | -319 Thousand | 186 Thousand | 32 Thousand | 1.07 Million | 1.45 Million |
Investments in PPE | -619 Thousand | -378 Thousand | -333 Thousand | -351 Thousand | -86 Thousand | -224 Thousand |
Acquisitions | 675 Thousand | 59 Thousand | 519 Thousand | 383 Thousand | 1.15 Million | 1.68 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -619 Thousand | -378 Thousand | -333 Thousand | 383 Thousand | 1.04 Million | 1.68 Million |
Financing Cash Flow | -14.86 Million | -16 Million | -19.35 Million | -17.99 Million | -11.65 Million | -19.29 Million |
Debt repayment | - | - | - | -104.62 Million | -7.79 Million | - |
Dividends payments | -14.86 Million | -16 Million | -19.35 Million | -19.35 Million | -19.23 Million | -18.65 Million |
Common Stock Repurchased | - | - | - | - | -37 Thousand | -636 Thousand |
Common Stock Issuance | - | - | - | - | -7.79 Million | - |
Other Financing Activities | - | - | - | 105.99 Million | 23.2 Million | -636 Thousand |
Accounts receivables | -1.03 Million | 121 Thousand | -655 Thousand | 3.87 Million | -4.37 Million | 3.77 Million |
Accounts payables | -1.83 Million | 2.4 Million | 160 Thousand | -550 Thousand | 1.22 Million | -3.75 Million |
Inventory | 514 Thousand | -400 Thousand | -493 Thousand | 588 Thousand | 1.21 Million | -854 Thousand |
Other working capital | -326 Thousand | 570 Thousand | 294 Thousand | 1.59 Million | -3.61 Million | 874 Thousand |
Cash at beginning of period | 6.23 Million | 7.31 Million | 10.25 Million | 7.6 Million | 22.32 Million | 23.95 Million |
Cash at end of period | 1.83 Million | 6.23 Million | 7.31 Million | 10.25 Million | 7.6 Million | 22.32 Million |
Capital Expenditure | -619 Thousand | -378 Thousand | -333 Thousand | -351 Thousand | -86 Thousand | -224 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -4.39 Million | -1.08 Million | -2.94 Million | 2.65 Million | -14.71 Million | -1.63 Million |
Free Cash Flow | 9.79 Million | 14.85 Million | 15.89 Million | 20.26 Million | -4.22 Million | 15.97 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.21 Million | 7.91 Million | 6.02 Million | 29.43 Million | 11.59 Million | 6.4 Million |
Depreciation & Amortization | 139 Thousand | 128 Thousand | 102 Thousand | 363 Thousand | 101 Thousand | 106 Thousand |
Deferred income taxes | 496 Thousand | 187 Thousand | 1.09 Million | 10.61 Million | 4.79 Million | 1.2 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.34 Million | 4.01 Million | -4.4 Million | -2.68 Million | -246 Thousand | -489 Thousand |
Other non-cash items | -142 Thousand | 5.93 Million | 6.98 Million | -22.97 Million | -12.84 Million | -3.59 Million |
Investing Cash Flow | -291 Thousand | -477 Thousand | -9.17 Million | 56 Thousand | -64 Thousand | -293 Thousand |
Investments in PPE | -292 Thousand | -615 Thousand | -9.25 Million | -619 Thousand | -69 Thousand | -373 Thousand |
Acquisitions | 1000.00 | 138 Thousand | 79 Thousand | 675 Thousand | 5000.00 | 80 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 138 Thousand | -9.17 Million | -619 Thousand | 5000.00 | 80 Thousand |
Financing Cash Flow | -2.58 Million | -2.58 Million | -3.72 Million | -14.86 Million | -3.7 Million | -3.72 Million |
Debt repayment | - | -10.29 Million | -10.29 Million | - | - | - |
Dividends payments | -2.58 Million | -2.58 Million | -3.72 Million | -14.86 Million | -3.7 Million | -3.72 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -10.29 Million | 10.29 Million | - | - | - |
Accounts receivables | -2.84 Million | 3.77 Million | -2.11 Million | -1.03 Million | 2.68 Million | -5.51 Million |
Accounts payables | 5.28 Million | -746 Thousand | -1.24 Million | -1.83 Million | -2.84 Million | 5.15 Million |
Inventory | 182 Thousand | 813 Thousand | -1.42 Million | 514 Thousand | -219 Thousand | -371 Thousand |
Other working capital | -277 Thousand | 174 Thousand | 386 Thousand | -326 Thousand | 140 Thousand | 241 Thousand |
Cash at beginning of period | 12.44 Million | 4.04 Million | 1.83 Million | 6.23 Million | 2.71 Million | 3.97 Million |
Cash at end of period | 14.61 Million | 12.44 Million | 4.04 Million | 1.83 Million | 1.83 Million | 2.71 Million |
Capital Expenditure | -292 Thousand | -615 Thousand | -9.25 Million | -619 Thousand | -69 Thousand | -373 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 2.17 Million | 8.4 Million | 2.21 Million | -4.39 Million | -888 Thousand | -1.25 Million |
Free Cash Flow | 4.75 Million | 21.14 Million | -4.43 Million | 9.79 Million | 2.8 Million | 2.38 Million |
HOVS
UNICHEMLAB
601012
PTHRF
7283
EDVMF